These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8277984)

  • 1. [Hepatitis B in children in 4 university centers in The Netherlands].
    Nuysink M; Rothbarth PH; Bijleveld CM; Houwen RH; Tolboom JJ; Sinaasappel M
    Ned Tijdschr Geneeskd; 1993 Dec; 137(50):2584-8. PubMed ID: 8277984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kiszkis H
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):315-23. PubMed ID: 9017146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G; Giustina G; Sanchez-Tapias J; Quero C; Mas A; Olivotto PG; Solinas A; Almasio P; Hadziyannis S; Degos F; de Moura MC; Krogsgaard K; Pantalena M; Realdi G; Corrocher R; Schalm SW
    Am J Gastroenterol; 1998 Jun; 93(6):896-900. PubMed ID: 9647014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
    Carreño V; Porres JC; Ruiz-Moreno M; Gutiez J; Bartolomé FJ
    Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
    Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
    Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome in children with chronic hepatitis B: a 24-year observation period.
    Iorio R; Giannattasio A; Cirillo F; D' Alessandro L; Vegnente A
    Clin Infect Dis; 2007 Oct; 45(8):943-9. PubMed ID: 17879906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
    Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
    Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
    Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
    Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
    Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma (CHC) in patients chronically infected with HBV].
    Zielińska W; Kiszkis H; Dybicki J; Zbrzeźniak G; Zółtowska A; Jankowski Z; Sliwińska I
    Przegl Epidemiol; 1991; 45(4):279-85. PubMed ID: 1668701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
    Lazăr C; Grigorescu-Sido P; Manasia R; Mireştean S; Skorka C; Neculoiu D; Molnar G; Cocean S
    Rom J Gastroenterol; 2005 Sep; 14(3):219-24. PubMed ID: 16200230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
    Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.